Weaker Buy Today ACHN ranks #565 as BUY CANDIDATE. Stronger Buy
Today ACHN ranks #565 as BUY CANDIDATE.

ACHN stock Achillion Pharmaceuticals

ACHN stock
Achillion Pharmaceuticals

March 19, 2019
Change 2.29%
Chart period: 2018-12-20 - 2019-03-19





Will ACHN stock price go up or down on Thu, 21 Mar 2019?

Achillion Pharmaceuticals Forecast and Stock Analysis

Technical ACHN stock analysis for March 19, 2019.

Buy candidate since 2019-03-05 Gain 13.41%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.47
ROA -22.84

Achillion Pharmaceuticals gained 2.29% in the last trading day, rising from $3.06 to $3.13 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 7 of the last 10 days and is up by 13.41% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.21 million more shares were traded than the day before. In total, 1.44 million shares bought and sold for approximately $4.52 million.

Close price at the end of the last trading day (Tuesday, 19th Mar 2019) of the ACHN stock was $3.13. This is 2.29% more than the trading day before Monday, 18th Mar 2019.

During day the stock fluctuated 3.47% from a day low at $3.03 to a day high of $3.13.

30 day high of the ACHN stock price was $3.13 and low was $2.36.
90 day high was $3.13 and low was $1.29.
52 week high for the Achillion Pharmaceuticals - $4.06 and low - $1.29.


Achillion Pharmaceuticals lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 77.21% during the next 3 months and, with 90% probability hold a price between $4.78 and $5.85 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Achillion Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $3.01 and $2.54. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday March 07, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

The stock had a Golden Star Signal* on Thursday January 24, 2019 in the short-term chart.

* Golden Star Signal* is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 76 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Achillion Pharmaceuticals finds support from accumulated volume at $3.05.

Support: $3.05 Price: $3.13


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.11 between high and low, or 3.47%. For the last week, the stock has had a daily average volatility of 5.09%.

Our recommended stoploss: $2.99 (-4.38%) (This stock has high daily movements and this gives high risk. The RSI14 is 76 and this increases the risk substantially. There is a buy signal from pivot bottom found 8 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Buy Candidate

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Weaker Buy Today ACHN ranks #565 as BUY CANDIDATE. Stronger Buy
Today ACHN ranks #565 as BUY CANDIDATE.